Intriguingly, the study uncovered that CD8+ T cells played a secondary role, while tumor-specific antibodies induced by MCMV-TRP2 were crucial for a strong and long-lasting anti-melanoma effect [93]. The gene discussed is CD8A; the disease is melanoma.